This Canadian biotech stock will beat the market, analyst says In a March 10 update, Leede analyst Douglas Loe maintained a “Speculative Buy” rating and US$16.00 target on Satellos Bioscience (...
#All #posts #Analysts #Life #Sciences #MSLE
Origin | Interest | Match